Amarin Corporation plc (AMRN)
USD 0.4
(-6.25%)
USD 0.4
(-6.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -191.04 Million USD | 8.0% |
| 2022 | -207.65 Million USD | 1.53% |
| 2021 | -210.87 Million USD | -18.6% |
| 2020 | -177.81 Million USD | 69.61% |
| 2019 | -585.01 Million USD | -246.41% |
| 2018 | -168.87 Million USD | -444.52% |
| 2017 | 49.01 Million USD | 169.34% |
| 2016 | 18.19 Million USD | -86.8% |
| 2015 | 137.89 Million USD | 28.49% |
| 2014 | 107.31 Million USD | 89.54% |
| 2013 | 56.62 Million USD | 315.6% |
| 2012 | -26.26 Million USD | 77.33% |
| 2011 | -115.83 Million USD | -269.45% |
| 2010 | -31.35 Million USD | 40.0% |
| 2009 | -52.25 Million USD | -364.97% |
| 2008 | -11.23 Million USD | 30.8% |
| 2007 | -16.24 Million USD | 55.87% |
| 2006 | -36.8 Million USD | -9.1% |
| 2005 | -33.73 Million USD | -275.25% |
| 2004 | -8.98 Million USD | -130.57% |
| 2003 | 29.4 Million USD | 17.75% |
| 2002 | 24.97 Million USD | 14.4% |
| 2001 | 21.82 Million USD | 181.93% |
| 2000 | 7.74 Million USD | -8.65% |
| 1999 | 8.47 Million USD | -3.69% |
| 1998 | 8.8 Million USD | -5.38% |
| 1997 | 9.3 Million USD | 8.14% |
| 1996 | 8.6 Million USD | 169.92% |
| 1995 | -12.3 Million USD | 0.0% |
| 1993 | -9.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -206.08 Million USD | -7.87% |
| 2024 Q3 | -148.72 Million USD | 28.62% |
| 2024 Q2 | -208.35 Million USD | -1.1% |
| 2023 Q3 | -261.84 Million USD | -17.14% |
| 2023 Q1 | -181.57 Million USD | 12.56% |
| 2023 Q2 | -223.52 Million USD | -23.11% |
| 2023 FY | -191.04 Million USD | 8.0% |
| 2023 Q4 | -191.04 Million USD | 27.04% |
| 2022 FY | -207.65 Million USD | 1.53% |
| 2022 Q1 | -208.75 Million USD | 1.01% |
| 2022 Q2 | -217.82 Million USD | -4.35% |
| 2022 Q4 | -207.65 Million USD | 9.94% |
| 2022 Q3 | -230.57 Million USD | -5.85% |
| 2021 Q3 | -214.14 Million USD | 32.69% |
| 2021 Q2 | -318.14 Million USD | -12.82% |
| 2021 FY | -210.87 Million USD | -18.6% |
| 2021 Q4 | -210.87 Million USD | 1.53% |
| 2021 Q1 | -281.97 Million USD | -58.58% |
| 2020 Q2 | -182.24 Million USD | 35.53% |
| 2020 Q1 | -282.68 Million USD | 51.68% |
| 2020 Q3 | -188.48 Million USD | -3.43% |
| 2020 Q4 | -177.81 Million USD | 5.66% |
| 2020 FY | -177.81 Million USD | 69.61% |
| 2019 Q2 | -144.99 Million USD | -12.52% |
| 2019 Q1 | -128.86 Million USD | 23.7% |
| 2019 FY | -585.01 Million USD | -246.41% |
| 2019 Q4 | -585.01 Million USD | 3.1% |
| 2019 Q3 | -603.73 Million USD | -316.37% |
| 2018 Q4 | -168.87 Million USD | -635.44% |
| 2018 FY | -168.87 Million USD | -444.52% |
| 2018 Q1 | -9.93 Million USD | -120.26% |
| 2018 Q2 | 14.76 Million USD | 248.67% |
| 2018 Q3 | 31.54 Million USD | 113.58% |
| 2017 Q3 | 45.82 Million USD | 9.14% |
| 2017 FY | 49.01 Million USD | 169.34% |
| 2017 Q1 | 32.35 Million USD | 77.79% |
| 2017 Q2 | 41.99 Million USD | 29.78% |
| 2017 Q4 | 49.01 Million USD | 6.96% |
| 2016 FY | 18.19 Million USD | -86.8% |
| 2016 Q3 | -173 Thousand USD | -100.1% |
| 2016 Q4 | 18.19 Million USD | 10619.65% |
| 2016 Q2 | 174.11 Million USD | 7.43% |
| 2016 Q1 | 162.08 Million USD | 17.54% |
| 2015 FY | 137.89 Million USD | 28.49% |
| 2015 Q3 | 112.13 Million USD | 18.65% |
| 2015 Q1 | 66.18 Million USD | -38.33% |
| 2015 Q2 | 94.5 Million USD | 42.8% |
| 2015 Q4 | 137.89 Million USD | 22.97% |
| 2014 Q3 | 87.99 Million USD | 53.46% |
| 2014 Q1 | 81.52 Million USD | 43.99% |
| 2014 Q2 | 57.33 Million USD | -29.67% |
| 2014 Q4 | 107.31 Million USD | 21.96% |
| 2014 FY | 107.31 Million USD | 89.54% |
| 2013 FY | 56.62 Million USD | 315.6% |
| 2013 Q1 | 37.42 Million USD | 242.52% |
| 2013 Q2 | 87.31 Million USD | 133.3% |
| 2013 Q4 | 56.62 Million USD | 305.88% |
| 2013 Q3 | 13.95 Million USD | -84.02% |
| 2012 Q4 | -26.26 Million USD | 68.86% |
| 2012 Q3 | -84.32 Million USD | 31.34% |
| 2012 FY | -26.26 Million USD | 77.33% |
| 2012 Q2 | -122.81 Million USD | -1.05% |
| 2012 Q1 | -121.53 Million USD | -4.92% |
| 2011 Q3 | -125.29 Million USD | 4.33% |
| 2011 Q1 | -128.96 Million USD | -311.32% |
| 2011 FY | -115.83 Million USD | -269.45% |
| 2011 Q2 | -130.96 Million USD | -1.55% |
| 2011 Q4 | -115.83 Million USD | 7.55% |
| 2010 Q4 | -31.35 Million USD | 0.0% |
| 2010 FY | -31.35 Million USD | 40.0% |
| 2010 Q2 | -37.74 Million USD | 0.0% |
| 2009 FY | -52.25 Million USD | -364.97% |
| 2009 Q2 | 4.82 Million USD | 0.0% |
| 2009 Q4 | -51.68 Million USD | 0.0% |
| 2008 FY | -11.23 Million USD | 30.8% |
| 2008 Q2 | -26.34 Million USD | -328.22% |
| 2008 Q1 | -6.15 Million USD | 62.13% |
| 2007 Q4 | -16.24 Million USD | 21.67% |
| 2007 Q2 | -27.61 Million USD | 4.69% |
| 2007 Q1 | -28.96 Million USD | 21.28% |
| 2007 FY | -16.24 Million USD | 55.87% |
| 2007 Q3 | -20.73 Million USD | 24.9% |
| 2006 Q2 | -28.81 Million USD | 13.4% |
| 2006 FY | -36.8 Million USD | -9.1% |
| 2006 Q4 | -36.8 Million USD | -63.4% |
| 2006 Q3 | -22.52 Million USD | 21.84% |
| 2006 Q1 | -33.27 Million USD | 1.35% |
| 2005 Q4 | -33.73 Million USD | 0.0% |
| 2005 Q2 | -16.38 Million USD | 0.0% |
| 2005 FY | -33.73 Million USD | -275.25% |
| 2004 Q4 | -8.98 Million USD | -511.02% |
| 2004 Q3 | 2.18 Million USD | 217.88% |
| 2004 Q2 | 688 Thousand USD | 0.0% |
| 2004 FY | -8.98 Million USD | -130.57% |
| 2003 Q2 | -11.23 Million USD | 0.0% |
| 2003 FY | 29.4 Million USD | 17.75% |
| 2003 Q4 | 29.4 Million USD | 111.5% |
| 2003 Q3 | 13.9 Million USD | 223.77% |
| 2002 Q4 | 24.97 Million USD | 0.0% |
| 2002 FY | 24.97 Million USD | 14.4% |
| 2001 Q4 | 21.82 Million USD | 0.0% |
| 2001 FY | 21.82 Million USD | 181.93% |
| 2000 Q4 | 7.74 Million USD | 0.0% |
| 2000 FY | 7.74 Million USD | -8.65% |
| 1999 FY | 8.47 Million USD | -3.69% |
| 1998 FY | 8.8 Million USD | -5.38% |
| 1998 Q3 | 8.8 Million USD | 0.0% |
| 1997 Q3 | 9.3 Million USD | 0.0% |
| 1997 FY | 9.3 Million USD | 8.14% |
| 1996 Q3 | 8.6 Million USD | 0.0% |
| 1996 FY | 8.6 Million USD | 169.92% |
| 1995 FY | -12.3 Million USD | 0.0% |
| 1995 Q3 | -12.3 Million USD | 0.0% |
| 1993 FY | -9.1 Million USD | 0.0% |
| 1993 Q3 | -9.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -241.509% |
| Alkermes plc | -166.73 Million USD | -14.574% |
| Agenus Inc. | 274.13 Million USD | 169.688% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.216% |
| Aptorum Group Limited | 1.35 Million USD | 14177.636% |
| Ardelyx, Inc. | 34.51 Million USD | 653.547% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4563.551% |
| Bicycle Therapeutics plc | -481.46 Million USD | 60.321% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 628.275% |
| ChromaDex Corporation | -24.04 Million USD | -694.411% |
| Chimerix, Inc. | -25.51 Million USD | -648.677% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2841.646% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -706.859% |
| CRISPR Therapeutics AG | -150.84 Million USD | -26.647% |
| Precision BioSciences, Inc. | -85.41 Million USD | -123.674% |
| Dyadic International, Inc. | -6.37 Million USD | -2895.25% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1099.021% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2592.368% |
| Lantern Pharma Inc. | -21.7 Million USD | -780.236% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -72.829% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2136.171% |
| Incyte Corporation | -3.17 Billion USD | 93.983% |
| IO Biotech, Inc. | -140.69 Million USD | -35.779% |
| Jaguar Health, Inc. | 29.39 Million USD | 749.995% |
| Novavax, Inc. | -298.29 Million USD | 35.956% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3679.539% |
| Opthea Limited | 28.15 Million USD | 778.471% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1037.888% |
| ContextLogic Inc. | -232 Million USD | 17.655% |
| MiMedx Group, Inc. | -33.9 Million USD | -463.523% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1973.86% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8145.049% |
| NextCure, Inc. | -6.47 Million USD | -2849.514% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -278.29% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2894.827% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1670.631% |
| Vaxcyte, Inc. | -368.22 Million USD | 48.119% |
| PDS Biotechnology Corporation | -32.7 Million USD | -484.061% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1205.684% |
| Pharming Group N.V. | 109.8 Million USD | 273.983% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -998.183% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -9.022% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -931.541% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -931.541% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2590.704% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3160.068% |
| Acelyrin, Inc. | -216.9 Million USD | 11.924% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3305.186% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10981.206% |
| Summit Therapeutics Inc. | 34.67 Million USD | 650.96% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2708.173% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11079.31% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -3.485% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -146.659% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3051.435% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 191582.324% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 30520.382% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -63.218% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -13.557% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 272.31% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2415.008% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -47.962% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2870.865% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 21.176% |
| Immix Biopharma, Inc. | -17.5 Million USD | -991.047% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 39.679% |
| MEI Pharma, Inc. | -3.7 Million USD | -5056.275% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1626.976% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 218.114% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 787.367% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2592.368% |
| Precigen, Inc. | -481 Thousand USD | -39617.256% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1456.722% |
| AlloVir, Inc. | -62.69 Million USD | -204.728% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -243.511% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 409.798% |
| ImmuCell Corporation | 10.99 Million USD | 1838.219% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -23.934% |
| Onconetix, Inc. | 5.33 Million USD | 3683.274% |
| PureTech Health plc | -167.19 Million USD | -14.26% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -527.183% |
| Elevation Oncology, Inc. | -19.11 Million USD | -899.268% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3791.628% |
| Seer, Inc. | -4.24 Million USD | -4405.66% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -694.775% |
| Innoviva, Inc. | 255.56 Million USD | 174.753% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -241.973% |
| ESSA Pharma Inc. | -33.62 Million USD | -468.206% |
| GlycoMimetics, Inc. | -40.98 Million USD | -366.128% |
| GT Biopharma, Inc. | -1.02 Million USD | -18611.068% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -181.841% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 411.866% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -42.483% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1278.753% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -561.679% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -253490.676% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -519.014% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2231.218% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6005.43% |
| Soligenix, Inc. | -4.95 Million USD | -3758.149% |
| Century Therapeutics, Inc. | 847 Thousand USD | 22654.9% |
| Kura Oncology, Inc. | -20.11 Million USD | -849.597% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -366.794% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2174.827% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10586.937% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5875.602% |
| Autolus Therapeutics plc | -186.59 Million USD | -2.38% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -287.474% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 30.731% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 657.488% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 216.227% |
| GRI Bio, Inc. | -1.79 Million USD | -10548.829% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2026.673% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -474.435% |
| IGM Biosciences, Inc. | -72.6 Million USD | -163.119% |
| INmune Bio, Inc. | -25.41 Million USD | -651.8% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 226.558% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -277.11% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1075.676% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6522.007% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 602.538% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -363.858% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 699.153% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 150.546% |
| Verastem, Inc. | -37.27 Million USD | -412.474% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2005.588% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -268.362% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1162.24% |
| Histogen Inc. | -7.48 Million USD | -2451.623% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -784.165% |
| Surrozen, Inc. | -32.66 Million USD | -484.864% |
| Organovo Holdings, Inc. | -1.5 Million USD | -12576.841% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4444.797% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1107.584% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7402.752% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4696.728% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2179.401% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -339.759% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1210.57% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 39.695% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -26357.635% |
| Apollomics, Inc. | -27.39 Million USD | -597.354% |
| Mesoblast Limited | 55.96 Million USD | 441.368% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1209.929% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -655.338% |
| Synaptogenix, Inc. | -28.66 Million USD | -566.539% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -20310.256% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 492.022% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22060.125% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2529.203% |
| Exelixis, Inc. | -73.05 Million USD | -161.52% |
| Better Therapeutics, Inc. | -860 Thousand USD | -22113.953% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -695.569% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 20.852% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26054.194% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2468.386% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 15334.45% |
| Gritstone bio, Inc. | 39.49 Million USD | 583.768% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -127.155% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7157.973% |
| Avid Bioservices, Inc. | 169.72 Million USD | 212.557% |
| Insmed Incorporated | 721.62 Million USD | 126.474% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1989.807% |
| MediWound Ltd. | -5.32 Million USD | -3489.628% |
| OmniAb, Inc. | 9.2 Million USD | 2175.845% |
| Alector, Inc. | -35.63 Million USD | -436.072% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 322.214% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3776.623% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1543.009% |
| Zai Lab Limited | -775 Million USD | 75.35% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 156.097% |
| Aura Biosciences, Inc. | -21.52 Million USD | -787.526% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -131.62% |
| Immunic, Inc. | -45.34 Million USD | -321.35% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 1.126% |
| Veracyte, Inc. | -203.82 Million USD | 6.272% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 129.93% |
| FibroGen, Inc. | 56.76 Million USD | 436.534% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2245.312% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6657.498% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9127.434% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.162% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5618.048% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -15.109% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1169.533% |
| Galecto, Inc. | -21.21 Million USD | -800.452% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -703.195% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.173% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -680.647% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1560.207% |
| XBiotech Inc. | -200.02 Million USD | 4.491% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -127.155% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4319.081% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -441.758% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -147.403% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3456.879% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -12.103% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -106.811% |
| Vaxxinity, Inc. | 10.13 Million USD | 1985.511% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 125.947% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1674.22% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -189.648% |
| NexImmune, Inc. | -3.13 Million USD | -5996.419% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5433.104% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1164.207% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -604.945% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2028.33% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -153253.402% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -370.867% |
| Ainos, Inc. | 4.07 Million USD | 4784.732% |
| Pluri Inc. | 22.82 Million USD | 936.83% |
| Prothena Corporation plc | -608.34 Million USD | 68.597% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -60.868% |
| Celularity Inc. | 65.19 Million USD | 393.051% |
| Rallybio Corporation | -24.1 Million USD | -692.631% |
| Cue Biopharma, Inc. | -33.81 Million USD | -464.89% |
| MeiraGTx Holdings plc | -40.3 Million USD | -374.021% |
| Omeros Corporation | 331.17 Million USD | 157.685% |
| Humacyte, Inc. | -22.48 Million USD | -749.595% |
| Immunocore Holdings plc | -358.59 Million USD | 46.725% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -677.375% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -518.232% |
| Blueprint Medicines Corporation | 702.83 Million USD | 127.181% |
| CalciMedica, Inc. | -5.53 Million USD | -3354.611% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -1.498% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1770.374% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -377.159% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -474.505% |
| Pulmatrix, Inc. | -10.41 Million USD | -1733.925% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3096.252% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -400.865% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -71.487% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -218.697% |
| Cytokinetics, Incorporated | 642.37 Million USD | 129.74% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3180.783% |
| Nutriband Inc. | -251.65 Thousand USD | -75812.85% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -459.923% |
| Vor Biopharma Inc. | 4.3 Million USD | 4542.791% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.835% |
| Evogene Ltd. | -19.63 Million USD | -873.006% |
| ProKidney Corp. | -56.23 Million USD | -239.711% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -292.505% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1968.162% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.007% |
| CorMedix Inc. | -43.05 Million USD | -343.737% |
| BioLineRx Ltd. | 7.33 Million USD | 2704.144% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -595.576% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 513.981% |
| Atai Life Sciences N.V. | -28.55 Million USD | -568.954% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8664.784% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -737.307% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1177.192% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -154.469% |
| MediciNova, Inc. | -50.78 Million USD | -276.185% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -142.421% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -849155.39% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2860.672% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 4.394% |
| Biomea Fusion, Inc. | -166.57 Million USD | -14.691% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -6.741% |
| Mereo BioPharma Group plc | -51.46 Million USD | -271.175% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -101.425% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 34.967% |
| Absci Corporation | -72.59 Million USD | -163.148% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4283.968% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 18.511% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -102.779% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -99.632% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -388.931% |
| Allakos Inc. | -24.97 Million USD | -664.925% |
| Imunon, Inc. | -4.21 Million USD | -4433.619% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1195.889% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -41.093% |
| BioAtla, Inc. | -109.01 Million USD | -75.248% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26054.194% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -20245.048% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1696.523% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -801.005% |
| XOMA Corporation | -29 Million USD | -558.759% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1053.623% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2018.9% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2464.64% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -53.278% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 8.226% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -133.605% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -105.944% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -22135.051% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4868.531% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11871.593% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 113.835% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15978.981% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4450.717% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 268.345% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 265573.444% |
| Orgenesis Inc. | 21.78 Million USD | 976.974% |
| Entera Bio Ltd. | -10.62 Million USD | -1697.347% |
| GH Research PLC | -78.07 Million USD | -144.682% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -757.143% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -616.606% |
| Xencor, Inc. | 29.64 Million USD | 744.447% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9598.387% |
| Replimune Group, Inc. | 1.41 Million USD | 13629.745% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -77904.802% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -51.119% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15978.981% |
| Portage Biotech Inc. | -4.98 Million USD | -3735.374% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -849155.39% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -188.92% |
| OncoCyte Corporation | -6.56 Million USD | -2810.864% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 21387.857% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4093.48% |
| Purple Biotech Ltd. | -14.13 Million USD | -1251.252% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -704.176% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2818.869% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1044.489% |
| HilleVax, Inc. | -165.48 Million USD | -15.442% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7427.187% |
| Tharimmune, Inc. | -10.93 Million USD | -1646.995% |
| Genprex, Inc. | -6.73 Million USD | -2735.419% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 48.201% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -115.962% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -13535.974% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5659.515% |
| OKYO Pharma Limited | -826.84 Thousand USD | -23004.609% |
| Savara Inc. | 153 Thousand USD | 124962.745% |
| Curis, Inc. | -23.88 Million USD | -699.766% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3603.825% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -24518.176% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2977.32% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 16221.519% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.521% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1648.324% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 68.589% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -2.939% |
| Erasca, Inc. | -37.21 Million USD | -413.328% |
| bluebird bio, Inc. | 108.57 Million USD | 275.959% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14733.53% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 150.44% |
| DBV Technologies S.A. | -126.98 Million USD | -50.442% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14733.53% |
| Moderna, Inc. | -2.9 Billion USD | 93.428% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1745.44% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1657.821% |
| Molecular Templates, Inc. | 707 Thousand USD | 27121.216% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -508.97% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 155.117% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -132.8% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -108.263% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -491.968% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -455.737% |
| MacroGenics, Inc. | -66.98 Million USD | -185.198% |
| RenovoRx, Inc. | -1.17 Million USD | -16186.445% |
| Adicet Bio, Inc. | -138.78 Million USD | -37.65% |
| Prime Medicine, Inc. | -27.94 Million USD | -583.726% |
| Aditxt, Inc. | 18.12 Million USD | 1154.253% |
| Adagene Inc. | -87.62 Million USD | -118.014% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4486.323% |
| Quantum-Si incorporated | -118.55 Million USD | -61.138% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 630.593% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2455.997% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -293.824% |
| SciSparc Ltd. | -2.06 Million USD | -9151.332% |
| Vericel Corporation | 1.27 Million USD | 15060.063% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1493.102% |
| Minerva Neurosciences, Inc. | 41 Million USD | 565.903% |
| Generation Bio Co. | 31.44 Million USD | 707.479% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -8.939% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -517.793% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 263.852% |
| Invivyd, Inc. | -198.47 Million USD | 3.747% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -111.632% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7867.675% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -169.869% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2699.121% |
| 2seventy bio, Inc. | 181.71 Million USD | 205.132% |
| ADMA Biologics, Inc. | 90.06 Million USD | 312.111% |
| Clene Inc. | 3.34 Million USD | 5819.76% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2003.339% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -788.104% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2860.672% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 44.485% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -634.778% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 207.528% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4569.116% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3919.272% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3567.499% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -46.611% |
| Evaxion Biotech A/S | 5.28 Million USD | 3713.498% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -69.711% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -45.529% |
| Trevena, Inc. | 2.25 Million USD | 8560.585% |
| Surrozen, Inc. | -32.66 Million USD | -484.864% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -270.879% |
| Cingulate Inc. | 3.08 Million USD | 6297.199% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6404.597% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2758.133% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1956.133% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -140.838% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -45.331% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -81.009% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4745.488% |
| Kronos Bio, Inc. | -36.05 Million USD | -429.872% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2130.396% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13201.739% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -252.109% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1425.157% |
| ImmunityBio, Inc. | 618.22 Million USD | 130.901% |
| Korro Bio, Inc. | -132.94 Million USD | -43.701% |
| Kineta, Inc. | -4.54 Million USD | -4107.003% |
| BioVie Inc. | -17.73 Million USD | -977.353% |
| Codexis, Inc. | -43.27 Million USD | -341.497% |
| Celularity Inc. | 65.19 Million USD | 393.051% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5928.4% |
| Celcuity Inc. | 6.78 Million USD | 2916.242% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5577.36% |
| Cibus, Inc. | -8.07 Million USD | -2264.942% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4417.38% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4280.306% |
| IN8bio, Inc. | -16.38 Million USD | -1065.66% |
| Kodiak Sciences Inc. | -103.87 Million USD | -83.913% |
| Annexon, Inc. | -193.75 Million USD | 1.401% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 530766.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -991.72% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5338.087% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 118.121% |
| Eyenovia, Inc. | 1.25 Million USD | 15277.54% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 810.054% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5790.842% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -474.608% |
| Arcellx, Inc. | -296.95 Million USD | 35.668% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -879.391% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -224.484% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -821.696% |
| Moolec Science SA | 117.61 Thousand USD | 162526.881% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -397.513% |
| Geron Corporation | 14.76 Million USD | 1394.221% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -403.824% |
| Royalty Pharma plc | 5.65 Billion USD | 103.376% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -35.086% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2633.272% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3462.279% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -35.748% |
| Humacyte, Inc. | -22.48 Million USD | -749.595% |
| Structure Therapeutics Inc. | -124.33 Million USD | -53.644% |
| 89bio, Inc. | -289.05 Million USD | 33.908% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -656.834% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -10614.526% |
| Genelux Corporation | -6.89 Million USD | -2669.097% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -515.087% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 328.519% |
| Notable Labs, Ltd. | -9.77 Million USD | -1854.173% |
| Liquidia Corporation | -80.17 Million USD | -138.276% |
| Mustang Bio, Inc. | -3.73 Million USD | -5013.49% |
| Immunovant, Inc. | -635.22 Million USD | 69.926% |
| Quantum-Si incorporated | -118.55 Million USD | -61.138% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -987.679% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4511.151% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2479.968% |
| Acasti Pharma Inc. | -23 Million USD | -730.428% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5573.508% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1075.676% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -38.696% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6030.225% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -759.302% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -928.811% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -12.856% |
| PepGen Inc. | -60.67 Million USD | -214.884% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -731.476% |
| United Therapeutics Corporation | -507.7 Million USD | 62.371% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -898.85% |
| Solid Biosciences Inc. | -47.75 Million USD | -300.084% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22060.125% |
| Immuneering Corporation | -54.94 Million USD | -247.707% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4444.797% |
| Silo Pharma, Inc. | -3.52 Million USD | -5320.639% |
| Belite Bio, Inc | -87.27 Million USD | -118.904% |
| XOMA Corporation | -29 Million USD | -558.759% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -170.224% |
| Bionomics Limited | 227 Million USD | 184.155% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -64.29% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7442.045% |
| uniQure N.V. | -102.95 Million USD | -85.564% |
| Cassava Sciences, Inc. | -121.13 Million USD | -57.707% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4486.323% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 566.509% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1497.191% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6074.132% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 180326.415% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5790.842% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2245.312% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2476.052% |
| Altimmune, Inc. | -134.48 Million USD | -42.051% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 196.453% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7442.045% |
| Compugen Ltd. | -12.9 Million USD | -1380.471% |
| Peak Bio, Inc. | 10.34 Million USD | 1947.554% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -67405.3% |
| Benitec Biopharma Inc. | -50.58 Million USD | -277.684% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -83.097% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1072.461% |
| Zura Bio Limited | -99.8 Million USD | -91.411% |
| PolyPid Ltd. | 6.17 Million USD | 3196.272% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 357.744% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1072.461% |
| Instil Bio, Inc. | 75.35 Million USD | 353.51% |
| argenx SE | -2.02 Billion USD | 90.584% |
| Immunome, Inc. | -97.02 Million USD | -96.89% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -749.255% |
| Verona Pharma plc | -220.44 Million USD | 13.338% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -166.284% |
| Shattuck Labs, Inc. | -121.42 Million USD | -57.333% |
| CervoMed Inc. | -7.79 Million USD | -2351.479% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -2.987% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4268.626% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -45.013% |
| Moolec Science SA | 117.61 Thousand USD | 162526.881% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8249.734% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1301.632% |
| AnaptysBio, Inc. | -18.15 Million USD | -952.504% |
| Design Therapeutics, Inc. | -18.15 Million USD | -952.562% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -171.437% |
| NeurAxis, Inc. | 145.7 Thousand USD | 131218.737% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1800.855% |
| Lumos Pharma, Inc. | -28.49 Million USD | -570.48% |
| Achilles Therapeutics plc | -126.92 Million USD | -50.515% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -166.284% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -29033.942% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -819.619% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13201.739% |
| Nutriband Inc. | -251.65 Thousand USD | -75812.85% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1350.459% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2467.742% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 156.156% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 904.887% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 57.307% |
| Palisade Bio, Inc. | -12.06 Million USD | -1483.686% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -36.155% |
| Beam Therapeutics Inc. | -262.72 Million USD | 27.284% |
| Neurogene Inc. | -131.95 Million USD | -44.777% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 975.688% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3814.754% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 49.352% |
| Sesen Bio, Inc. | -112.55 Million USD | -69.733% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -91.308% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8037.004% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -389.52% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -129.389% |
| Athira Pharma, Inc. | -88.99 Million USD | -114.654% |
| Vaccinex, Inc. | -1.28 Million USD | -14732.298% |
| HCW Biologics Inc. | 2.85 Million USD | 6787.493% |
| XOMA Corporation | -29 Million USD | -558.759% |
| Nektar Therapeutics | 210.24 Million USD | 190.868% |
| Arvinas, Inc. | -313.8 Million USD | 39.12% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11871.593% |
| Merus N.V. | -192.88 Million USD | 0.956% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 418.48% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2653.531% |
| Rezolute, Inc. | -68.16 Million USD | -180.249% |
| Clene Inc. | 3.34 Million USD | 5819.76% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1348.699% |
| BeyondSpring Inc. | -13.75 Million USD | -1288.877% |
| Synlogic, Inc. | -6.68 Million USD | -2757.741% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 16946.561% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2159.491% |
| Peak Bio, Inc. | 10.34 Million USD | 1947.554% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -131.788% |
| Krystal Biotech, Inc. | -350.23 Million USD | 45.454% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 253.909% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -13.044% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5951.039% |
| MannKind Corporation | 143.89 Million USD | 232.76% |
| Ikena Oncology, Inc. | -109.15 Million USD | -75.016% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2423.313% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -477.16% |
| Gossamer Bio, Inc. | 180.35 Million USD | 205.924% |
| CohBar, Inc. | -5.93 Million USD | -3121.188% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -542.194% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4283.968% |
| Legend Biotech Corporation | -949.39 Million USD | 79.878% |
| Mural Oncology plc | -255.84 Million USD | 25.329% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 693.016% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3955.498% |
| Disc Medicine, Inc. | -358.28 Million USD | 46.679% |
| Champions Oncology, Inc. | 4.81 Million USD | 4070.075% |
| REGENXBIO Inc. | 54.76 Million USD | 448.817% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -70943.149% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -26.496% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2019.839% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -136.779% |
| Vaxart, Inc. | -8.24 Million USD | -2218.165% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -280.71% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -50.229% |
| Cellectis S.A. | -43.85 Million USD | -335.617% |
| Longeveron Inc. | -2.9 Million USD | -6469.464% |
| Repare Therapeutics Inc. | -107.85 Million USD | -77.122% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 119.728% |
| Inozyme Pharma, Inc. | 12 Million USD | 1691.47% |
| Revolution Medicines, Inc. | -608.2 Million USD | 68.589% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -15431.707% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 27.941% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -27.299% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1120.937% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -25716.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.002% |
| Denali Therapeutics Inc. | -74.86 Million USD | -155.179% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1493.102% |
| Veru Inc. | 4.77 Million USD | 4096.679% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1598.737% |
| Cingulate Inc. | 3.08 Million USD | 6297.199% |
| Passage Bio, Inc. | 4.58 Million USD | 4266.63% |
| Context Therapeutics Inc. | -14.44 Million USD | -1222.092% |
| Exicure, Inc. | 5.84 Million USD | 3366.199% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 17.075% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -382.79% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1317.513% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -224.782% |
| Nuvalent, Inc. | -335.38 Million USD | 43.039% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11115.135% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -156.492% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2048.931% |
| OmniAb, Inc. | 9.2 Million USD | 2175.845% |
| Anew Medical, Inc. | 1.43 Million USD | 13436.452% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1266.175% |
| Lipocine Inc. | -4.75 Million USD | -3918.01% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -73.945% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1354.284% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -277.11% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 867.475% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2742.434% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -190.215% |
| Ocugen, Inc. | -32.52 Million USD | -487.436% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -123.243% |
| Q32 Bio Inc. | -37.94 Million USD | -403.426% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -30320.382% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1312.078% |
| Equillium, Inc. | -22.39 Million USD | -753.162% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -647.184% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -485.531% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -76958.669% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 242.522% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6073.734% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 58265.698% |
| Dominari Holdings Inc. | 195 Thousand USD | 98069.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3527.174% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2042.425% |
| Bio-Techne Corporation | 267.74 Million USD | 171.351% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1078.604% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -61.769% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2173.474% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1410.078% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 22.062% |
| Nkarta, Inc. | 57.29 Million USD | 433.409% |
| BioCardia, Inc. | 212 Thousand USD | 90213.208% |
| Iterum Therapeutics plc | 13.43 Million USD | 1521.64% |